| Literature DB >> 35157056 |
John Giardina1, Alyssa Bilinski2, Meagan C Fitzpatrick3, Emily A Kendall4, Benjamin P Linas5, Joshua Salomon6, Andrea L Ciaranello7.
Abstract
Importance: With recent surges in COVID-19 incidence and vaccine authorization for children aged 5 to 11 years, elementary schools face decisions about requirements for masking and other mitigation measures. These decisions require explicit determination of community objectives (eg, acceptable risk level for in-school SARS-CoV-2 transmission) and quantitative estimates of the consequences of changing mitigation measures. Objective: To estimate the association between adding or removing in-school mitigation measures (eg, masks) and COVID-19 outcomes within an elementary school community at varying student vaccination and local incidence rates. Design, Setting, and Participants: This decision analytic model used an agent-based model to simulate SARS-CoV-2 transmission within a school community, with a simulated population of students, teachers and staff, and their household members (ie, immediate school community). Transmission was evaluated for a range of observed local COVID-19 incidence (0-50 cases per 100 000 residents per day, assuming 33% of all infections detected). The population used in the model reflected the mean size of a US elementary school, including 638 students and 60 educators and staff members in 6 grades with 5 classes per grade. Exposures: Variant infectiousness (representing wild-type virus, Alpha variant, and Delta variant), mitigation effectiveness (0%-100% reduction in the in-school secondary attack rate, representing increasingly intensive combinations of mitigations including masking and ventilation), and student vaccination levels were varied. Main Outcomes and Measures: The main outcomes were (1) probability of at least 1 in-school transmission per month and (2) mean increase in total infections per month among the immediate school community associated with a reduction in mitigation; multiple decision thresholds were estimated for objectives associated with each outcome. Sensitivity analyses on adult vaccination uptake, vaccination effectiveness, and testing approaches (for selected scenarios) were conducted.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35157056 PMCID: PMC8845023 DOI: 10.1001/jamanetworkopen.2021.47827
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Selected Input Parameters for Agent-Based Dynamic Transmission Model of 30-Day SARS-CoV-2 Outcomes in Elementary Schools
| Parameter | Values | Source |
|---|---|---|
| Full day in-school symptomatic adult-to-adult secondary attack rate (unmitigated) | ||
| Wild-type | 2.0% | Bilinski et al,[ |
| Alpha | 3.5% | Davies et al,[ |
| Delta | 7.0% | Singanayagam et al,[ |
| Attack rate multipliers by location and duration of contact (relative to full day in-school contact) | ||
| At-home contacts | 2 | Assumption based on documented increased attack rates in the home (Thompson et al,[ |
| Brief contacts at school (random and specials classes) | 0.125 | Assumed to last 1 period out of an 8-period day, with infection risk proportional to time |
| Brief contacts at school (staff-staff contacts) | 0.25 | Assumed to last 1 period out of an 8-period day, but with higher risk from closer proximity (eg, break room) |
| Contacts between households (eg, childcare) | 1 | Assumption; in-school mitigation measures are not applied to these contacts |
| Infectiousness (relative to symptomatic adults) | ||
| Student (in-school and asymptomatic at-home) | 0.5 | Literature review and calibration from Bilinski et al,[ |
| Asymptomatic adult | 0.5 | Byambasuren et al,[ |
| Student (symptomatic at-home) | 1 | Paul et al,[ |
| Overdispersion multiplier (for adults) | Lognormal distribution (0.84, 0.3)/0.84 | Kerr et al,[ |
| Susceptibility (relative to adults) | ||
| Student | 0.5 | Literature review and calibration from Bilinski et al,[ |
| Length of latent and incubation periods and infection (days) | ||
| Time from exposure to infectious (latent period) | Maximum of gamma distribution (5.8, 0.95) minus normal distribution (2, 0.4); 1 | Lauer et al,[ |
| Time from exposure to symptoms (if symptoms occur) (incubation period) | Gamma distribution (5.8, 0.95) | Lauer et al,[ |
| Duration of infectious period | Lognormal distribution (5, 2) | Li et al,[ |
| Probability clinical/symptomatic infection | ||
| Probability of asymptomatic infection | ||
| Student | 0.4 | Fontanet et al,[ |
| Adult | 0.2 | Byambasuren et al,[ |
| Probability of subclinical infection, including asymptomatic | ||
| Student | 0.8 | Han et al,[ |
| Adult | 0.4 | Upper bound of estimate from Byambasuren et al,[ |
| Polymerase chain reaction test characteristics | ||
| Sensitivity (during infectious period) | 0.9 (asymptomatic testing); 1 (symptomatic testing) | Atkeson et al,[ |
| Test turnaround time, d | 1 | Assumption |
| Weekly screening parameters | ||
| Testing uptake (fraction of school screened each week) | 90% | Assumption |
| Testing day | Monday | Assumption |
| Hospitalization risk after SARS-CoV-2 infection | ||
| Student (unvaccinated) | 0.1% | US Centers for Disease Control and Prevention,[ |
| Adult (unvaccinated) | 2.4% | US Centers for Disease Control and Prevention,[ |
| All (vaccinated) | 0% | Rosenberg et al,[ |
| Vaccine uptake | ||
| Student | 0%, 25%, 50%, and 70% (base case); 90% (sensitivity analysis) | Assumption |
| Adult | 70% (base case); 50% and 90% (sensitivity analysis) | US Centers for Disease Control and Prevention,[ |
| Vaccine effectiveness | ||
| All individuals | 70% reduction in infection risk (base case); 25%, 50%, and 90% (sensitivity analysis) | Rosenberg et al,[ |
| Risk of exposure in wider local community | ||
| Observed local incidence rate | 0-50 cases per 100 000 residents per d | Assumption |
| Actual incidence of infections within immediate school community sourced from wider local community | 3 × observed local incidence rate | Assumption |
eMethods 1 in the Supplement includes an explanation of how these parameters were derived from the listed sources.
Baseline parameter from Bilinski, et al.[16]
This value was set to match the generation time implied by observed estimates of the serial interval and presymptomatic transmission, without assuming waning infectiousness.
Figure 1. Model-Estimated Probability of at Least 1 In-School SARS-CoV-2 Transmission Over 30 Days in a Simulated Elementary School Setting
Panels reflect decreasingly transmissible variants from top to bottom and increasing student vaccination coverage from left to right. Bands of mitigation effectiveness reflect approximate assumptions for the A, B, and C mitigation intervention scenarios described in the Methods section. The contour lines represent thresholds for different probability levels; probabilities are lower than the threshold above the contour line and higher below it. The arrow indicates the local COVID-19 incidence rate at which a school might opt to move to the next more intensive mitigation strategy at a baseline of 30% effectiveness, if the objective is to maintain a probability of the 1 in-school transmission per month at less than 50%. Adult vaccination coverage is assumed to be 70% in all scenarios.
Figure 2. Model-Estimated Mean Number of Additional Cases Over 30 Days in the Immediate School Community Associated With Reductions in Mitigation Effectiveness in the Simulated Elementary School Setting
Panels reflect decreasingly transmissible variants from top to bottom, and larger differences in effectiveness between intensive and less intensive mitigation measures from left to right. The changes in mitigation effectiveness reflect the midpoints or bounds of the A and B mitigation scenarios presented in Figure 1: 60% to 40% mitigation effectiveness (smaller effectiveness decrease); 70% to 30% effectiveness (moderate effectiveness decrease); and 80% to 20% effectiveness (larger effectiveness decrease). Adult vaccination coverage is assumed to be 70% in all scenarios.
Figure 3. Observed Local Incidence Decision Thresholds for the Delta Variant Baseline Scenario
Units of observed local incidence thresholds are cases per 100 000 residents per day. It was assumed that 33% of all actual cases are observed.
aIf observed local incidence is above these thresholds, additional mitigation measures beyond baseline will be needed to achieve each objective (eg, keep probability of at least 1 in-school transmission per month below 50%).
bThe Delta baseline scenario presented in this table reflects 70% adult vaccination coverage, 70% vaccine effectiveness, and no weekly screening, except for the 90% student vaccination rows, which reflect 90% adult vaccination coverage (since it is assumed adult coverage will always be at least as high as student coverage).
cOnly includes estimated mean additional cases and hospitalizations in the immediate school community (students, teachers, staff, and household members). The potential for additional cases in the wider community stemming from in-school transmission was not modeled.
Figure 4. Weekly Screening and Vaccine Effectiveness Sensitivity Analyses for the Mean Number of Additional Cases Over 30 Days in the Immediate School Community Associated With Reductions in Mitigation Effectiveness in the Simulated Elementary School Setting
A, This scenario is for the Delta variant, with weekly in-school screening (90% uptake) and 70% vaccine effectiveness. B, This scenario is for the Delta variant, with 50% vaccine effectiveness and only diagnostic testing. Adult vaccination coverage is assumed to be 70% in both scenarios. Panels reflect larger differences in effectiveness between intensive and less intensive mitigation measures from left to right.